Edward Tenthoff Analyst Performance

Sr Research Analyst at Piper Sandler

Edward Tenthoff is a stock analyst at Piper Sandler focused in the medical sector, covering 57 publicly traded companies. Over the past year, Edward Tenthoff has issued 14 stock ratings, including and buy recommendations. While full access to Edward Tenthoff's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Edward Tenthoff's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 238 Last 10 Years
Buy Recommendations: 80.00% 180 Buy Ratings
Companies Covered: 57 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	80.0%	180 ratings
Hold	18.2%	41 ratings
Sell	1.8%	4 ratings

Out of 225 total stock ratings issued by Edward Tenthoff at Piper Sandler, the majority (80.0%) have been Buy recommendations, followed by 18.2% Hold and 1.8% Sell.

Best & Worst Calls

Best Call
000000.0%
PTI
Dec 2019
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
VSAR
Sep 2017
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	93.0% of companies on NASDAQ	53 companies
OTCMKTS	3.5% of companies on OTCMKTS	2 companies
NYSEAMERICAN	1.8% of companies on NYSEAMERICAN	1 company
NYSE	1.8% of companies on NYSE	1 company

Edward Tenthoff, an analyst at Piper Sandler, currently covers 57 companies listed on NASDAQ, OTCMKTS, NYSEAMERICAN and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 53 companies	93.0%
	Miscellaneous 2 companies	3.5%
	Energy 1 company	1.8%
	Transportation 1 company	1.8%

Edward Tenthoff of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on and Energy companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 27 companies	47.4%
PHARMACEUTICAL PREPARATIONS 13 companies	22.8%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 5 companies	8.8%
MED - DRUGS 4 companies	7.0%
Miscellaneous 2 companies	3.5%
BIOTECHNOLOGY 2 companies	3.5%
MED PRODUCTS 1 company	1.8%
MED INSTRUMENTS 1 company	1.8%
SOLAR 1 company	1.8%
TRANS - AIRLINE 1 company	1.8%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
KPTI Karyopharm Therapeutics	10/9/2025	Reiterated Rating	$5.75	$12.00	Overweight
CAMP CAMP4 Therapeutics	9/15/2025	Lower Price Target	$3.25	$12.00	Overweight
ALNY Alnylam Pharmaceuticals	8/1/2025	Boost Price Target	$392.24	$449.00	Overweight
NXTC NextCure	7/15/2025	Set Price Target	$4.85	$15.00	Overweight
CAPR Capricor Therapeutics	7/11/2025	Reiterated Rating	$7.94	$20.00	Overweight
INO Inovio Pharmaceuticals	7/9/2025	Initiated Coverage	$1.34	$5.00	Overweight
CRSP CRISPR Therapeutics	6/27/2025	Reiterated Rating	$47.45	$105.00	Overweight
BMEA Biomea Fusion	6/3/2025	Initiated Coverage	$1.55	$7.00	Overweight
FULC Fulcrum Therapeutics	5/29/2025	Reiterated Rating	$6.90	$9.00	Overweight
ITOS iTeos Therapeutics	5/14/2025	Reiterated Rating	$7.33	$12.00	Overweight
ARVN Arvinas	5/2/2025	Reiterated Rating	$7.02	$14.00	Overweight
IPSC Century Therapeutics	3/20/2025	Lower Price Target	$0.54	$2.00	Overweight
DYN Dyne Therapeutics	2/28/2025	Lower Price Target	$13.17	$48.00	Overweight
MESO Mesoblast	2/7/2025	Reiterated Rating	$19.85	$24.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.